DRUG SCHEDULE FOR TREATMENT OF P vivax MALARIA CASES
|
(As per NVDBCP Guide Line)
|
Chloroquine & Primaquine :
Chloroquine & Primaquine |
||||||
Age in years | To be given just after collection of B/S | After obtaining B/S report | ||||
Chloroquine Tab (consecutive 3 days) | Primaquine Tab (1st day single dose) | Pv (Tab Primaquine for 14 days) | Pf | |||
1st Day | 2nd Day | 3rd Day | ||||
0 -1 | ½ (75mg) | ½ (75mg) | ¼ (37.5 mg) | 0 | Nil | No medicine |
1+ - 4 | 1 (150 mg) | 1 (150 mg) | ½ (75 mg) | 1 (7.5 mg) | 2.5 mg daily | |
4+ - 8 | 2 (300 mg) | 2 (300 mg) | 1 (150 mg) | 2 (15 mg) | 5 mg daily | |
8+ - 14 | 3 (450 mg) | 3 (450 mg) | 1½ (225 mg) | 4 ( 30 mg) | 10 mg daily | |
14 above | 4 (600 mg) | 4 (600 mg) | 2 (300 mg) | 6 (45 mg) | 15 mg daily |
NOTE: Tab Primaquine is contraindicated in Pregnancy
For Chloroquine resistant area (2nd line drug)
DRUG SCHEDULE FOR TREATMENT OF P falciperum MALARIA CASES of Jalpaiguri district
Sulphadoxine-Pyrimethamine & Artesunate Combination Therapy :
Sulphadoxine-Pyrimethamine & Artesunate Combination Therapy | |||||
Age in Yr. | Artesunate (AS) & SP) | Day-1 (No. of Tab) | Day-2 (No. of Tab) | Day-3 (No. of Tab) | Day-2 (Tab Primaquine) |
Below 1Yr. | AS | ½ | ½ | ½ | 0 |
SP | ¼ | NIL | NIL | ||
1 to 4Yr | AS | 1 | 1 | 1 | 1 (7.5mg) |
SP | ½ | NIL | NIL | ||
4+ to 8Yr | AS | 2 | 2 | 2 | 2(15mg) |
SP | 1 | NIL | NIL | ||
8+ to 14Yr. | AS | 3 | 3 | 3 | 4(30 mg) |
SP | 2 | NIL | NIL | ||
14 & above | AS | 4 | 4 | 4 | 6(45 mg) |
SP | 3 | NIL | NIL |
NOTE :
• Jalpaiguri district is a High risk district as a whole.
• 2nd line drug are using for falciparum infection. Sulphadoxine-Pyrimethamine (SP), Artesunate (AS) should always be used in combination. Otherwise resistance to this drug will develop soon.
Now in our district we are using age wise combiblister pack of ACT.